|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1970)) |
| Is prodrug? | Yes |
| Active form | 5-fluorouracil |
IUPAC Name ![]() |
| 5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 2010 | floxuridine |
Synonyms ![]() |
| 5-fluoro-2'-deoxyuridine |
| floxidine |
| FUDR® |
Database Links ![]() |
|
| CAS Registry No. | 50-91-9 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL917 |
| DrugBank Ligand | DB00322 |
| PubChem CID | 5790 |
| Search Google for chemical match using the InChIKey | ODKNJVUHOIMIIZ-RRKCRQDMSA-N |
| Search Google for chemicals with the same backbone | ODKNJVUHOIMIIZ |
| Search PubMed clinical trials | floxuridine |
| Search PubMed titles | floxuridine |
| Search PubMed titles/abstracts | floxuridine |
| Wikipedia | Floxuridine |
| Comments |
| Floxuridine is metabolized to 5-fluorouracil when given by rapid injection, but is converted to floxuridine monophosphate when given as continuous infusion. 5-fluorouracil is considered the active drug. |